Looking like the future is already there, telehealth is the combination of modern digital communication technologies and new healthcare industry trends, which allows patients to get access to health care services distantly with the help of their mobile devices or Read More

International pharmacies are helpful in finding, ordering and purchasing necessary medicines at a bargain prices that cannot be obtained in your country. Online ordering in international pharmacies aims at expanding the range and improving the quality of the pharmaceutical sector. Read More

Bullous Pemphigoid (BP) is an auto-immune blistering disease of the skin which affects 30,000 Americans and an estimated 90,000 people worldwide (1/3 with moderate to severe disease). Most of the patients are over 60 years old, require several visits before Read More

Immune Canadian pharmacy (NASDAQ: IMNP) (the “Company”) announced today that on May 24, 2017, the Company received written notice from Nasdaq that the Company has regained compliance with the minimum bid price rule, as required by a decision of the Read More

In line with this prioritization, the Company’s Board of Directors (the “Board”) has authorized Dr. Daniel Teper to lead the Company’s oncology business within the Company’s Cytovia, Inc. subsidiary and to pursue a possible spin-off of Cytovia into a separate, Read More

Immune Pharma long term shareholders recognize the disconnect between the intrinsic value of each the key assets of the company and the stock price/ market valuation. The company first identified the potential to structure subsidiaries around asset groups: Immuno-Inflammation, Immuno-Oncology and Pain. Read More

Like many micro-cap companies, Immune Pharmaceuticals (NASDAQ:IMNP) has had to overcome the challenges of structured financings. Stock price and liquidity are key drivers for an early stage biotech company to raise sufficient capital to advance its pipeline. The good news Read More